Labcorp launches FDA-cleared rapid fentanyl test for quick detection
Labcorp introduces a FDA-cleared rapid fentanyl test that delivers results in just 10 minutes, aiding quick clinical decisions in emergency and hospital settings by detecting the fentanyl metabolite norfentanyl in urine.
Labcorp has unveiled a rapid fentanyl test that provides results in 10 minutes. The Labcorp Fentanyl Urine Visual Test is cleared by the U.S. Food and Drug Administration (FDA).
The test is targeted at emergency departments, hospitals, and clinics through Labcorp Point of Care, aiming to aid clinical decision making.
The test assesses fentanyl exposure by detecting norfentanyl, the primary fentanyl metabolite, which can remain present in urine up to 48 hours after initial exposure. This provides a longer detection window than fentanyl itself, which may clear within hours. The test is FDA-cleared for use by qualified professionals in Clinical Laboratory Improvement Amendments (CLIA)-certified settings. Results are intended for preliminary rapid screening purposes and should be confirmed using appropriate laboratory methods, per the standard practice for rapid testing.
